These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34664732)

  • 1. The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies.
    Hofer F; Kazem N; Schweitzer R; Horvat P; Winter MP; Koller L; Hengstenberg C; Sulzgruber P; Niessner A
    Clin Cardiol; 2021 Dec; 44(12):1692-1699. PubMed ID: 34664732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus.
    Lattuca B; Bouziri N; Kerneis M; Portal JJ; Zhou J; Hauguel-Moreau M; Mameri A; Zeitouni M; Guedeney P; Hammoudi N; Isnard R; Pousset F; Collet JP; Vicaut E; Montalescot G; Silvain J;
    J Am Coll Cardiol; 2020 Apr; 75(14):1676-1685. PubMed ID: 32273033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of patients with left ventricular thrombus in East China.
    Li C; Lau W; Qian N; Song L; Jin C; Zhou D; Yu Y; Pan X; Zhou Q
    Front Cardiovasc Med; 2022; 9():944687. PubMed ID: 36158827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation.
    Zhang Q; Zhang Z; Zheng H; Wang C; Yu M; Si D; Zhang W
    Thromb J; 2023 Jul; 21(1):75. PubMed ID: 37430265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year clinical outcome of patients with left ventricular thrombus after acute myocardial infarction discharged on triple or dual antithrombotic therapy.
    De Luca L; Putini RL; Natale E; Terranova A; Piazza V; Pugliese M; De Lio L; Biffani E; Bellettini E; Uguccioni M; Musumeci F
    J Thromb Thrombolysis; 2022 Feb; 53(2):410-416. PubMed ID: 34613575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention.
    Sia CH; Leow AS; Tan BY; Low CJ; Kaur R; Yeo TC; Chan MY; Tay EL; Yeo LL; Yap ES; Loh JP
    Thromb Res; 2020 Oct; 194():16-20. PubMed ID: 32559523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes.
    Kim SE; Lee CJ; Oh J; Kang SM
    ESC Heart Fail; 2023 Jun; 10(3):1987-1995. PubMed ID: 37009745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic effect of left ventricular thrombus formation after acute myocardial infarction in the contemporary era of primary percutaneous coronary intervention: A meta-analysis.
    Chen PF; Tang L; Yi JL; Pei JY; Hu XQ
    Eur J Intern Med; 2020 Mar; 73():43-50. PubMed ID: 31708360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is 3-6 months anticoagulation with warfarin necessary after left ventricular thrombectomy with left ventricular aneurysm surgery?
    Zhang S; Huang S; Tiemuerniyazi X; Song Y; Feng W
    J Card Surg; 2022 Dec; 37(12):5103-5110. PubMed ID: 36378885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of left ventricular thrombosis in post-acute myocardial infarction patients stratified by antithrombotic strategies: A meta-analysis with meta-regression.
    Low CJ; Leow AS; Syn NL; Tan BY; Yeo LL; Tay EL; Yeo TC; Chan MY; Loh JP; Sia CH
    Int J Cardiol; 2021 Apr; 329():36-45. PubMed ID: 33412177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.
    De Luca L; Di Lenarda A; Rubboli A; Bolognese L; Gonzini L; Fortuni F; Navazio A; Poletti F; Ledda A; Urbinati S; Gabrielli D; Gulizia MM;
    Eur J Intern Med; 2021 Jun; 88():28-34. PubMed ID: 33838988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM
    JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study.
    De Luca L; Leonardi S; Cavallini C; Lucci D; Musumeci G; Caporale R; Abrignani MG; Lupi A; Rakar S; Gulizia MM; Bovenzi FM; De Servi S;
    Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):441-52. PubMed ID: 25414322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry.
    D'Ascenzo F; Grosso A; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Ali HH; Magnani G; Autelli M; Blanco PF; Garay A; Quadri G; Marra WG; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Raposeiras-Roubin S
    Int J Cardiol; 2018 Dec; 273():29-33. PubMed ID: 30228021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombus: A Systematic Review and Meta-analysis.
    Burmeister C; Beran A; Mhanna M; Ghazaleh S; Tomcho JC; Maqsood A; Sajdeya O; Assaly R
    Am J Ther; 2021 Apr; 28(4):e411-e419. PubMed ID: 33852473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients.
    Galli M; Andreotti F; Porto I; Crea F
    Europace; 2020 Apr; 22(4):538-546. PubMed ID: 31942971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy.
    Hamilos M; Petousis S; Xanthopoulou I; Goudevenos J; Kanakakis J; Sitafidis G; Vavouranakis M; Skalidis E; Kochiadakis G; Lekakis J; Vardas PE; Alexopoulos D
    Coron Artery Dis; 2018 Jan; 29(1):53-59. PubMed ID: 28834792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor.
    Verdoia M; Rolla R; Pergolini P; Gioscia R; Nardin M; Negro F; Viglione F; Suryapranata H; Kedhi E; De Luca G;
    Catheter Cardiovasc Interv; 2021 Dec; 98(7):1309-1316. PubMed ID: 33527669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome).
    Prati F; Romagnoli E; Gatto L; La Manna A; Burzotta F; Limbruno U; Versaci F; Fabbiocchi F; Di Giorgio A; Marco V; Ramazzotti V; Di Vito L; Trani C; Porto I; Boi A; Tavazzi L; Mintz GS
    Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.